| Name | Title | Contact Details |
|---|
Providence Plan is a Providence, RI-based company in the Business Services sector.
Industrial Laboratories is a Wheat Ridge, CO-based company in the Business Services sector.
Brady Corporation is an international manufacturer and marketer of complete solutions that identify and protect people, products and places.
TDK InvenSense is a prominent provider of intelligent sensor systems on chip (SoC) for motion and sound, primarily serving the consumer electronics market. Founded in 2003 and based in San Jose, California, the company operates as a subsidiary of TDK Corporation. InvenSense became part of TDKs MEMS Sensors Business Group in 2017 following a significant acquisition. The company specializes in a variety of sensor solutions, including MEMS sensors known for their high performance and low power consumption. Their offerings include motion tracking sensor systems, 6-axis inertial measurement units (IMUs), and sound and ultrasonic technologies. InvenSense has shipped over 500 million units of its sixth-generation IMUs, which are widely used in devices such as smartphones, wearables, and gaming controllers. Their technology is featured in products from major companies like Nintendo, Oculus, Samsung, and Apple, showcasing their impact on the consumer electronics landscape.
About Route 92 Medical, Inc. Route 92 Medical is on a mission to improve outcomes for patients undergoing minimally invasive brain procedures. At the core is a reconsidered procedural approach, cutting-edge engineering, and innovative product design. Our portfolio takes aim at the biggest challenges in neurointervention to deliver meaningful solutions to treat challenging diseases such as stroke. Founded by physicians, the company is focused upon developing thoughtful next generation products in collaboration with the worlds leading clinicians with the goal of improving procedural and patient outcomes. The Monopoint operating platform received U.S. FDA 510(k) clearance in 2020. The company is currently enrolling the SUMMIT MAX randomized controlled trial under an FDA-approved Investigational Device Exemption.